|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Costs and expenses: | |||||
| Cost of revenue (excluding depreciation and amortization) | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Depreciation and amortization | |||||
| Total operating costs and expenses | |||||
| Loss from operations | |||||
| Gain (loss) on change in fair value of warrant liabilities | |||||
| Interest income, net | |||||
| Offering costs associated with warrants | |||||
| Other income (expense), net | |||||
| Total net loss before income taxes | |||||
| Income tax benefit (expense) | |||||
| Net loss | |||||
| Net loss attributable to noncontrolling interests | |||||
| Net loss attributable to IonQ, Inc. | |||||
| Net loss per share attributable to IonQ, Inc. common stockholders-basic | |||||
| Net loss per share attributable to IonQ, Inc. common stockholders-diluted | |||||
| Weighted average shares used in computing net loss per share attributable to IonQ, Inc. common stockholders-basic | |||||
| Weighted average shares used in computing net loss per share attributable to IonQ, Inc. common stockholders-diluted | |||||
Loading...